Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Mark D. Soll x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objectives

To determine the efficacy of ivermectin (IVM) and milbemycin oxime (MBO) against induced heartworm infection, where monthly treatment is started 3 or 4 months after infection, and to monitor microfilaremia and antigenemia.

Animals

21 heartworm-naive Beagles.

Procedures

Each of 21 dogs was given 50 infective larvae of Dirofilaria immitis by SC inoculation. One group of 5 dogs served as nonmedicated controls, 2 groups of 5 dogs received IVM at 6 μg/kg of body weight or MBO at 500 μg/kg for 12 months beginning at postinfection (PI) month 4, and 2 groups of 3 dogs received IVM or MBO for 13 months beginning at PI month 3. Blood collected at intervals not >1 month beginning at PI month 4 was examined for microfilariae and antigen. Dogs were euthanatized at PI month 16.

Results

Adult worm counts, relative to controls, were reduced in the 4-month treatment groups by 95.1 (P < 0.01) and 41.4% for IVM and MBO, respectively. The difference between the IVM and MBO groups was significant (P < 0.01). Live worms were found in all MBO-treated (range, 8 to 27) and control dogs (range, 12 to 39) and in 3 of 5 IVM-treated dogs (range, 2 to 4). In the 3-month treatment groups, worm counts were reduced by 97.7 (P < 0.01) and 96.8% (P < 0.01) for IVM and MBO, respectively. Microfilariae were seen in all control dogs and in only 2 of the 16 treated dogs. The antigen response of MBO-treated dogs in the 4-month treatment group was only slightly weaker than that for control dogs. In all other treated dogs, this response was delayed and weaker.

Conclusion

Ivermectin is highly (≥ 95%) and significantly more effective than MBO against induced heartworm infection when 1 year of monthly prophylactic dosing is started 4 months after infection.

Clinical Relevance

In some cases of owner compliance failure, monthly administration of IVM gives a high level of protection against young adult heartworms. (Am J Vet Res1996;57:1189-1192)

Free access
in American Journal of Veterinary Research